Mir Imran

Mir Imran founded InCube Labs to focus on his passion: creating medical solutions that change the standard of care in critical healthcare markets. After attending medical school, Mir began his career as a healthcare entrepreneur in the late 1970's and has founded numerous game-changing companies since those early days. Over the decades, he has become one of the leading inventors and entrepreneurs in the field. Mir now holds more than 200 issued patents and is perhaps most well known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator.

As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen 'liquidity events' (IPO/Acquisition).

Mir's expertise spans a wide range of clinical areas from interventional cardiology to chronic pain, obesity and CNS disorders. Mir actively collaborates with the nation's top universities on research and development including Stanford, Rutgers, Johns Hopkins, UTSW, etc. Mir also founded InCube Ventures, a life sciences venture fund, where he has led investments in a range of promising ventures. Mir sits on Boards of several life sciences companies.

Mir has received a number of industry accolades for his work including being named one of the 'Top 50 Medical Device Inventors of All Time' by QMed and recognized as a National Academy of Inventors (NAI) fellow in 2015. He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. Mir also attended CMDNJ/Rutgers Medical School.